{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:44:30Z","timestamp":1767869070940,"version":"3.49.0"},"reference-count":13,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2025,11,10]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>The myopia control field stands at an ethical crossroads. Withholding proven soft contact lens interventions in control arms of myopia management trials is increasingly viewed as ethically questionable and operationally challenging, particularly given that MiSight 1-day contact lens has demonstrated efficacy in at least four randomised controlled trials. The recent methodological evolution towards non-inferiority trials against an established control rather than a placebo (single vision) is a welcome change. However, this shift raises a critical challenge: setting non-inferiority margins that are both clinically meaningful and statistically robust.<\/jats:p>","DOI":"10.1136\/bmjophth-2025-002341","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:15:32Z","timestamp":1764785732000},"page":"e002341","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Establishing non-inferiority margins in myopia management contact lens trials with an active control"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0280-0966","authenticated-orcid":false,"given":"Ravi Chandra","family":"Bakaraju","sequence":"first","affiliation":[{"name":"nthalmic Pty Ltd, Botany, New South Wales, Australia"},{"name":"School of Optometry, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-9699","authenticated-orcid":false,"given":"Daniel","family":"Tilia","sequence":"additional","affiliation":[{"name":"nthalmic Pty Ltd, Botany, New South Wales, Australia"},{"name":"School of Optometry, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2026010721205588000_10.1.e002341.1","doi-asserted-by":"publisher","DOI":"10.1111\/opo.13120"},{"key":"2026010721205588000_10.1.e002341.2","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-12-106","article-title":"Through the looking glass: understanding non-inferiority","volume":"12","author":"Schumi","year":"2011","journal-title":"Trials"},{"key":"2026010721205588000_10.1.e002341.3","unstructured":"U.S. FDA . Non-inferiority clinical trials to establish effectiveness: guidance for industry. 2016. Available: https:\/\/www.fda.gov\/media\/78504\/download [Accessed 3 Jun 2025]."},{"key":"2026010721205588000_10.1.e002341.4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00417-018-3906-z","article-title":"MiSight Assessment Study Spain (MASS). A 2-year randomized clinical trial","volume":"256","author":"Ruiz-Pomeda","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026010721205588000_10.1.e002341.5","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000001410"},{"key":"2026010721205588000_10.1.e002341.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-024-03678-1","article-title":"Impact of wearing dual-focus soft contact lenses on myopia progression: a one-year randomized clinical trial in Chinese school-age children","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"2026010721205588000_10.1.e002341.7","unstructured":"Arumugam B , Bradley A , Hammond D , et al . Efficacy of misight 1-day dual-focus lenses in controlling myopia progression in chinese children. AAO Conference, Indianopolis, IN 2024;E-Abstract 245034."},{"key":"2026010721205588000_10.1.e002341.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100923"},{"key":"2026010721205588000_10.1.e002341.9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/OPX.0000000000001977","article-title":"Efficacy in Myopia Control: Does Race Matter?","volume":"100","author":"Bullimore","year":"2023","journal-title":"Optom Vis Sci"},{"key":"2026010721205588000_10.1.e002341.10","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000002176"},{"key":"2026010721205588000_10.1.e002341.11","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/opo.13379","article-title":"Can we really distinguish \u201cresponders\u201d from \u201cnon-responders\u201d to myopia control interventions?","volume":"44","author":"Brennan","year":"2024","journal-title":"Ophthalmic Physiol Opt"},{"key":"2026010721205588000_10.1.e002341.12","doi-asserted-by":"crossref","first-page":"102256","DOI":"10.1016\/j.clae.2024.102256","article-title":"Soft peripheral contact lens for eye elongation control (SPACE): 1-year results of a double-blinded randomized controlled trial","volume":"47","author":"Lee","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"key":"2026010721205588000_10.1.e002341.13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/opo.13042","article-title":"Efficacy of contact lenses for myopia control: Insights from a randomised, contralateral study design","volume":"42","author":"Weng","year":"2022","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2025-002341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:21:40Z","timestamp":1767849700000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2025-002341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,3]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjophth-2025-002341"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2025-002341","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}